References
- Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63:297-301. https://doi.org/10.1136/ard.2003.006122
- Rose AL, Walton JN. Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis. Brain 1966;89: 747-768. https://doi.org/10.1093/brain/89.4.747
- Suda T, Kaida Y, Nakamura Y, Enomoto N, Fujisawa T, Imokawa S, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 2009; 103:846-853. https://doi.org/10.1016/j.rmed.2008.12.019
- Chen IJ, Tsai WP, Wu YJ, Luo SF, Ho HH, Liou LB, et al. Infections in polymyositis and dermatomyositis: analysis of 192 cases. Rheumatology (Oxford) 2010;49:2429-2437. https://doi.org/10.1093/rheumatology/keq279
- Choy EH, Isenberg DA. Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford) 2002;41:7-13.
- Kalluri M, Oddis CV. Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med 2010;31: 501-512. https://doi.org/10.1016/j.ccm.2010.05.008
- Scott DL, Kingsley GH. Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 2006;355:704-712. https://doi.org/10.1056/NEJMct055183